2025 Study Shows No Link Between Cannabis Use and Cognitive Decline in Older Adults
The cannabis cognitive aging study 2025 found no evidence that cannabis use accelerates cognitive decline or dementia risk in older adults. This large observational study combined data from two major cohorts and Mendelian randomisation analyses. The…
Behaviors Related to Medical Cannabis Use in Older Adults: A Qualitative Study
Medical cannabis use older adults is an emerging area of clinical interest due to unique behavioral patterns and risks. This qualitative study explores how older adults approach cannabis therapeutically. Understanding these behaviors helps guide safer…
Groundbreaking Study Finds New Side Effect from Smoking Cannabis
A new side effect from smoking cannabis has been discovered, highlighting cognitive decline risks in older adults. This finding expands knowledge of cannabis effects beyond younger users. Clinicians should consider these risks when advising older…
Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients
Medical cannabis counseling is increasingly important for older adults as many seek advice on pain, sleep, and anxiety. Physicians often feel underprepared to provide detailed, age-specific guidance. This study highlights the growing need for better…
Medical Cannabis in Older Adults: Promising Interest, Thin Evidence
Medical cannabis safety older adults is a critical concern due to limited evidence and unique risks in this population. Current studies mostly exclude adults over 60, leaving a gap in clinical guidance. Careful individualized decision-making is essential…
Older Adults on Medical Cannabis Face Doubled Intoxication Risk When Co-Prescribed Narrow Therapeutic Index Drugs
Medical cannabis drug interactions older adults face are a growing concern, especially with narrow therapeutic index drugs. A large Ontario cohort study found a 2.61-fold increase in intoxication risk among older adults co-prescribed cannabis and these…
Common But Manageable: What a 58-Trial Meta-Analysis Reveals About Cannabis Medicine Side Effects in Older Adults
Cannabinoid adverse events older adults are dose-dependent and mostly manageable according to a 58-trial meta-analysis. THC-containing medicines increase common side effects like dizziness and dry mouth in older adults. Serious adverse events do not…
Cannabinoid Safety in Adults Over 50: Meta-Analysis Review
This meta-analysis highlights cannabinoid safety older adults, showing low adverse event rates for THC and CBD alone. Combination THC:CBD products showed higher withdrawal rates. The study emphasizes cautious use and the need for controlled trials in…
Older Adults with COPD More Likely to Receive Potentially Risky Cannabinoid Prescriptions, Study Finds
Synthetic cannabinoid prescribing COPD older adults is more common than in those without COPD, according to a large population study. The study found higher frequency and doses of off-label synthetic cannabinoids among older adults with COPD. These…
Older Adults and Medical Cannabis: Promising Interest, Scarce Evidence
Medical cannabis older adults safety is a critical concern given limited evidence. Most studies focus on younger populations, leaving gaps in geriatric data. Risks include cognitive and cardiovascular effects unique to older adults.